BioPharma Credit PLC (BPCR) — Cash Flow Quality Index
BioPharma Credit PLC (BPCR) has a Cash Flow Quality Index of 0.46x as of June 2025. Operating cash flow of $33.76 Million is below net income of $72.78 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BPCR cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BioPharma Credit PLC Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for BioPharma Credit PLC across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of BioPharma Credit PLC to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for BioPharma Credit PLC (2017–2024)
Year-by-year earnings quality comparison for BioPharma Credit PLC. For live market cap and the full company financial profile, see how much is BioPharma Credit PLC worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | $111.91 Million | $122.18 Million | ▼ -19.4% |
| 2023 | 1.14x | $123.18 Million | $108.45 Million | ▲ +12.4% |
| 2022 | 1.01x | $184.28 Million | $182.31 Million | ▼ -11.0% |
| 2021 | 1.14x | $96.44 Million | $84.96 Million | ▲ +74.2% |
| 2020 | 0.65x | $58.07 Million | $89.14 Million | ▼ -39.4% |
| 2019 | 1.08x | $131.52 Million | $122.33 Million | ▲ +12.3% |
| 2018 | 0.96x | $67.14 Million | $70.15 Million | ▲ +12.7% |
| 2017 | 0.85x | $23.07 Million | $27.16 Million | — |